Ledger.Open graph →
SEC Form D · filed February 28, 2025

Eikon Therapeutics, Inc

Offering
$400.0M
Sold
$350.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HAYWARD, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Leon M. Chen · Hayward, CADirectorKenneth M. Frazier · Hayward, CADirectorRoger M. Perlmutter · Hayward, CAExec · DirectorJames M. Tananbaum · Hayward, CADirectorDror M. Berman · Hayward, CADirectorRobin M. Washington · Hayward, CADirectorNicholas Stageberg · Rochester, MNExec · DirectorRaymond Updyke · New York, NYDirectorAlicia Glen · New York, NYDirectorJoe D. Davis · Southlake, TXDirectorEric Newman · Jupiter, FLDirectorGeorge T. Hollan · Southlake, TXDirectorRobbie M. Huffines · Hayward, CADirectorJoshua M. Wolfe · Hayward, CADirectorSimon J. Cox · Central, Hong KongDirectorJoshua Stone · McKinney, TXDirectorTrevor Woolfe · Vancouver, British Columbia, CanadaExec · DirectorManasa Mantravadi · Indianapolis, INDirectorBhuplesh Gupta · Scottsdale, AZDirectorMatthew Jaffee · GLENCOE, ILDirectorRobbie M. Huffines · Hayward, CADirectorJoshua M. Wolfe · Hayward, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗